Literature DB >> 17656008

The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells.

Daniel J Pearce1, Dominique Bonnet.   

Abstract

OBJECTIVE: In murine hematopoietic tissue, direct repopulation experiments have demonstrated that the side population (SP) represents a remarkable enrichment of hematopoietic stem cells. Human SP has been phenotyped as negative for lineage antigens as well as CD34. However, in the 9 years since the original publication, no long-term hematopoietic reconstitution has been reported for the adult human SP/CD34(-) subset. Elevated levels of aldehyde dehydrogenase (ALDH) have been demonstrated in murine and human progenitor cells when compared to other hematopoietic cells.
METHODS: Here, we report the phenotype of human cord blood SP cells. We established the technique of simultaneous phenotyping, Hoechst exclusion, and ALDH labeling on murine tissues. We then performed the simultaneous analysis of phenotype, SP, and ALDH activity on human cord blood and bone marrow cells. Finally, we analyzed the phenotype and functional potential of human cord blood ALDH(+) cells to determine whether Lin(-)/CD34(-) cells are identified via this technique.
RESULTS: We demonstrate that human Lin(-)/CD34(-)/ALDH(+) cells are capable of long-term repopulation. Although the SP technique identifies cells that overlap with the ALDH(+) cell population, this is restricted to the CD34(+) cell subset.
CONCLUSION: Hoechst exclusion ability does not seem to be the method of choice for the isolation of human hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656008     DOI: 10.1016/j.exphem.2007.06.002

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  28 in total

Review 1.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Authors:  Ines A Silva; Shoumei Bai; Karen McLean; Kun Yang; Kent Griffith; Dafydd Thomas; Christophe Ginestier; Carolyn Johnston; Angela Kueck; R Kevin Reynolds; Max S Wicha; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2011-04-15       Impact factor: 12.701

3.  Lung epithelial healing: a modified seed and soil concept.

Authors:  Susan D Reynolds; Heather M Brechbuhl; Mary Kathryn Smith; Russell W Smith; Moumita Ghosh
Journal:  Proc Am Thorac Soc       Date:  2012-05

4.  Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities.

Authors:  Karine Vauchez; Jean-Pierre Marolleau; Michel Schmid; Patricia Khattar; Alain Chapel; Cyril Catelain; Séverine Lecourt; Jérôme Larghéro; Marc Fiszman; Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

5.  A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Authors:  Jonathan M Gerber; B Douglas Smith; Brownhilda Ngwang; Hao Zhang; Milada S Vala; Laura Morsberger; Steven Galkin; Michael I Collector; Brandy Perkins; Mark J Levis; Constance A Griffin; Saul J Sharkis; Michael J Borowitz; Judith E Karp; Richard J Jones
Journal:  Blood       Date:  2012-01-19       Impact factor: 22.113

6.  Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.

Authors:  Kevin Shoulars; Pamela Noldner; Jesse D Troy; Lynn Cheatham; Amanda Parrish; Kristin Page; Tracy Gentry; Andrew E Balber; Joanne Kurtzberg
Journal:  Blood       Date:  2016-03-11       Impact factor: 22.113

7.  Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.

Authors:  Garrett G Muramoto; J Lauren Russell; Rachid Safi; Alice B Salter; Heather A Himburg; Pamela Daher; Sarah K Meadows; Phuong Doan; Robert W Storms; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

Review 8.  Advances in complex multiparameter flow cytometry technology: Applications in stem cell research.

Authors:  Frederic Preffer; David Dombkowski
Journal:  Cytometry B Clin Cytom       Date:  2009-09       Impact factor: 3.058

Review 9.  Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.

Authors:  James P Sullivan; John D Minna; Jerry W Shay
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

Review 10.  Breast cancer stem cells: tools and models to rely on.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.